Table 10:
Potentially Relevant Ongoing Trials Identified of the Prolaris Cell Cycle Progression Test
| Trial Name | Trial Identifier | Estimated Primary Completion Datea |
|---|---|---|
| Open Registry Measuring Impact of Genomic Testing on Treatment Decision After Biopsy in Newly Diagnosed Prostate Cancer Patients (PROCEDE-2000) | NCT02209584 | September 2015 |
| Registry to Measure the Impact of Adding Genomic Testing (URO-006) | NCT02454595 | November 2016 |
a
Trial status information as reported on October 6, 2016.
Source: US National Institutes of Health, ClinicalTrials.gov.